JOSE&SALUA MEDICAL AESTHETIC SA
Company details
- Active NIF/CIF: A66813064
-
-
-
-
Address: RD SANT PERE Num.14 (BARCELONA).
-
-
Featured products:
More information on JOSE&SALUA MEDICAL AESTHETIC SA
-
14/05/2024 | BORME act no.: 220451 | Register: BARCELONACambio de domicilio social
-
21/11/2022 | BORME act no.: 507187 | Register: BARCELONACancelaciones de oficio de nombramientos
-
18/11/2022 | BORME act no.: 504500 | Register: BARCELONANombramientos
-
18/11/2022 | BORME act no.: 504500 | Register: BARCELONAModificaciones estatutarias
-
06/06/2018 | BORME act no.: 237471 | Register: BARCELONANombramientos
-
29/07/2016 | BORME act no.: 312796 | Register: BARCELONAConstitución
-
29/07/2016 | BORME act no.: 312796 | Register: BARCELONANombramientos
Other information
The CIF of JOSE&SALUA MEDICAL AESTHETIC SA is A66813064 and its current business status is active. The company is engaged in activities related to the CNAE code 6612 - Actividades de intermediación en operaciones con valores y otros activos. Its SIC code - also indicates the nature of its business.
JOSE&SALUA MEDICAL AESTHETIC SA employs a number of workers ranging from Between 1 and 9 employees, and records an annual turnover of less than 2 million euros. The company is registered in the Mercantile Registry of Barcelona and has a total of 4 registry positions.
Its last announcement in Borme was published on 14/05/2024, while its last deposit of ordinary annual accounts corresponds to the year 2023.
You can find contact information for JOSE&SALUA MEDICAL AESTHETIC SA, such as phone number, address, or website, in the Company Data section.
For more details about JOSE&SALUA MEDICAL AESTHETIC SA, you can review one of our available financial reports, the Annual Accounts of the company, or check its default incidents in the RAI delinquency file.
The financial, business, and legal information provided for JOSE&SALUA MEDICAL AESTHETIC SA comes from official sources and is updated daily.
Do you want to know more about JOSE&SALUA MEDICAL AESTHETIC SA??
Find out more about this company by consulting these reports: